2017
DOI: 10.1016/j.artere.2017.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Effect on the lipid parameters of an intervention to reduce weight in overweight and obese patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 26 publications
1
2
0
Order By: Relevance
“…In the present study, we have observed a reduction in triglycerides and an increase in HDLc levels in obese subjects who lost weight. These results are in accordance with previous studies reporting decreases in triglyceride levels after dietary treatment (Morel et al., ; Hernández‐Mijares et al., ; Kondo et al., ) and with studies showing that HDLc levels increase with weight loss after dietary therapy (Tárraga Marcos et al., ) or surgery (Sesti, Folli, Perego, Hribal, & Pontiroli, ; Gómez‐Abril et al., ). Furthermore, multiple studies have shown that weight loss produces an improvement in the hydrocarbon profile by reducing circulating levels of glucose, insulin and the HOMA‐IR index (Hermsdorff et al., ; Sesti et al., ), as well as blood pressure (Hermsdorff et al., ; Morel et al., ; Rothberg et al., ).…”
Section: Discussionsupporting
confidence: 92%
“…In the present study, we have observed a reduction in triglycerides and an increase in HDLc levels in obese subjects who lost weight. These results are in accordance with previous studies reporting decreases in triglyceride levels after dietary treatment (Morel et al., ; Hernández‐Mijares et al., ; Kondo et al., ) and with studies showing that HDLc levels increase with weight loss after dietary therapy (Tárraga Marcos et al., ) or surgery (Sesti, Folli, Perego, Hribal, & Pontiroli, ; Gómez‐Abril et al., ). Furthermore, multiple studies have shown that weight loss produces an improvement in the hydrocarbon profile by reducing circulating levels of glucose, insulin and the HOMA‐IR index (Hermsdorff et al., ; Sesti et al., ), as well as blood pressure (Hermsdorff et al., ; Morel et al., ; Rothberg et al., ).…”
Section: Discussionsupporting
confidence: 92%
“…Of the 103 included studies (Tables 1 and S1), 90 were trials of WLs, 36–125 and 13 were of WLMs 126–138 . Across the studies, there were a total of 36,805 participants, with the sample size of each study ranging from 30 44 to 2,161 participants 93 .…”
Section: Resultsmentioning
confidence: 99%
“…One hundred and twenty-four studies provided data on changes in cardiometabolic disease incidence or risk factors and were included here. 16–138…”
Section: Resultsmentioning
confidence: 99%